These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inhibiting the p53-MDM2 interaction: an important target for cancer therapy. Chène P Nat Rev Cancer; 2003 Feb; 3(2):102-9. PubMed ID: 12563309 [TBL] [Abstract][Full Text] [Related]
4. Exploiting the p53 pathway for cancer diagnosis and therapy. Lane DP Br J Cancer; 1999 Jul; 80 Suppl 1():1-5. PubMed ID: 10466753 [No Abstract] [Full Text] [Related]
5. Molecular biology. Getting p53 out of the nucleus. Gottifredi V; Prives C Science; 2001 Jun; 292(5523):1851-2. PubMed ID: 11397937 [No Abstract] [Full Text] [Related]
6. Strategies for manipulating the p53 pathway in the treatment of human cancer. Hupp TR; Lane DP; Ball KL Biochem J; 2000 Nov; 352 Pt 1(Pt 1):1-17. PubMed ID: 11062053 [TBL] [Abstract][Full Text] [Related]
7. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Boyd SD; Tsai KY; Jacks T Nat Cell Biol; 2000 Sep; 2(9):563-8. PubMed ID: 10980695 [TBL] [Abstract][Full Text] [Related]
8. P53 licensed to kill? Operating the assassin. Haupt S; Louria-Hayon I; Haupt Y J Cell Biochem; 2003 Jan; 88(1):76-82. PubMed ID: 12461776 [TBL] [Abstract][Full Text] [Related]
9. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Koumenis C; Alarcon R; Hammond E; Sutphin P; Hoffman W; Murphy M; Derr J; Taya Y; Lowe SW; Kastan M; Giaccia A Mol Cell Biol; 2001 Feb; 21(4):1297-310. PubMed ID: 11158315 [TBL] [Abstract][Full Text] [Related]
11. Deconstruction of p53 functions and regulation. Haupt Y; Robles AI; Prives C; Rotter V Oncogene; 2002 Nov; 21(54):8223-31. PubMed ID: 12447685 [TBL] [Abstract][Full Text] [Related]
12. The regulation of p53-mediated transcription and the roles of hTAFII31 and mdm-2. Lu H; Lin J; Chen J; Levine AJ Harvey Lect; 1994-1995; 90():81-93. PubMed ID: 8803320 [No Abstract] [Full Text] [Related]
13. The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein. Lopez-Borges S; Lazo PA Oncogene; 2000 Jul; 19(32):3656-64. PubMed ID: 10951572 [TBL] [Abstract][Full Text] [Related]
14. A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control. Li L; Liao J; Ruland J; Mak TW; Cohen SN Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1619-24. PubMed ID: 11172000 [TBL] [Abstract][Full Text] [Related]
15. Regulation of DNA binding and transactivation in p53 by nuclear localization and phosphorylation. Martinez JD; Craven MT; Joseloff E; Milczarek G; Bowden GT Oncogene; 1997 May; 14(21):2511-20. PubMed ID: 9191051 [TBL] [Abstract][Full Text] [Related]
16. p53-Mdm2--the affair that never ends. Alarcon-Vargas D; Ronai Z Carcinogenesis; 2002 Apr; 23(4):541-7. PubMed ID: 11960904 [TBL] [Abstract][Full Text] [Related]
17. Nuclear exclusion of p53 in a subset of tumors requires MDM2 function. Lu W; Pochampally R; Chen L; Traidej M; Wang Y; Chen J Oncogene; 2000 Jan; 19(2):232-40. PubMed ID: 10645001 [TBL] [Abstract][Full Text] [Related]
18. Turning the key on p53. Lane DP; Fischer PM Nature; 2004 Feb; 427(6977):789-90. PubMed ID: 14985740 [No Abstract] [Full Text] [Related]
19. P53 and prognosis: new insights and further complexity. Vousden KH; Prives C Cell; 2005 Jan; 120(1):7-10. PubMed ID: 15652475 [TBL] [Abstract][Full Text] [Related]
20. Cancer: pinning a change on p53. Ryan KM; Vousden KH Nature; 2002 Oct; 419(6909):795, 797. PubMed ID: 12397340 [No Abstract] [Full Text] [Related] [Next] [New Search]